Heald, Robert’s team published research in Journal of Medicinal Chemistry in 58 | CAS: 39546-32-2

Journal of Medicinal Chemistry published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, Category: piperidines.

Heald, Robert published the artcileNoncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study, Category: piperidines, the publication is Journal of Medicinal Chemistry (2015), 58(22), 8877-8895, database is CAplus and MEDLINE.

Because of their increased activity against activating mutants, first-generation epidermal growth factor receptor (EGFR) kinase inhibitors have had remarkable success in treating non-small-cell lung cancer (NSCLC) patients, but acquired resistance, through a secondary mutation of the gatekeeper residue, means that clin. responses only last for 8-14 mo. Addressing this unmet medical need requires agents that can target both of the most common double mutants: T790M/L858R (TMLR) and T790M/del(746-750) (TMdel). Herein we describe how a noncovalent double mutant selective lead compound was optimized using a strategy focused on the structure-guided increase in potency without added lipophilicity or reduction of three-dimensional character. Following successive rounds of design and synthesis it was discovered that cis-fluoro substitution on 4-hydroxy- and 4-methoxypiperidinyl groups provided synergistic, substantial, and specific potency gain through direct interaction with the enzyme and/or effects on the proximal ligand oxygen atom. Further development of the fluorohydroxypiperidine series resulted in the identification of a pair of diastereomers that showed 50-fold enzyme and cell based selectivity for T790M mutants over wild-type EGFR (wtEGFR) in vitro and pathway knock-down in an in vivo xenograft model.

Journal of Medicinal Chemistry published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, Category: piperidines.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Boy, Songuel’s team published research in Chemistry & Biodiversity in 18 | CAS: 39546-32-2

Chemistry & Biodiversity published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, HPLC of Formula: 39546-32-2.

Boy, Songuel published the artcileSynthesis, Spectroscopic Analysis, and in Vitro/in Silico Biological Studies of Novel Piperidine Derivatives Heterocyclic Schiff-Mannich Base Compounds, HPLC of Formula: 39546-32-2, the publication is Chemistry & Biodiversity (2021), 18(12), e2100433, database is CAplus and MEDLINE.

In the present study, 3-substitued-4-(4-hydroxybenzylidenamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones (S1-8) were synthesized by treating 4-hydroxybenzaldehyde (B) with eight different 3-substitued-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones (T1-8) in acetic acid medium, sep. The synthesized Schiff bases (S) were reacted with formaldehyde and secondary amine such as 4-piperidinecarboxyamide to afford novel heterocyclic bases. 3-Substitued-4-(4-hydroxybenzylidenamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones (T) were treated with 4-piperidinecarboxyamide in the presence of formaldehyde to synthesize eight new 1-(4-piperidinecarboxyamide-1-yl-methyl)-3-substitued-4-(4-hydroxybenzylidenamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones (M1-8). The structure characterization of compounds was carried out using 1H-NMR, IR, HR-MS, and 13C-NMR spectroscopic methods. The inhibitory properties of the newly synthesized compounds were calculated against the acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and glutathione S-transferase (GST) enzymes. Ki values were calculated in the range of 20.06±3.11-36.86±6.17 μM for GST, 17.87±2.91-30.53±4.25 μM for AChE, 9.08±0.69-20.02±2.88 μM for BChE, resp., Besides, IC50 values were also calculated Best binding scores of -inhibitors against used enzymes were calculated as -12.095 kcal/mol, -12.775 kcal/mol, and -9.336 kcal/mol, resp. While 5-oxo-triazole piperidine-4-carboxamide moieties have a critical role in the inhibition of AChE and GST enzymes, hydroxy benzyl moiety is important for BChE enzyme inhibition.

Chemistry & Biodiversity published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, HPLC of Formula: 39546-32-2.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Cogan, D. A.’s team published research in Bioorganic & Medicinal Chemistry Letters in 18 | CAS: 14613-37-7

Bioorganic & Medicinal Chemistry Letters published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Safety of (1-Methylpiperidin-3-yl)methanamine.

Cogan, D. A. published the artcileStructure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase, Safety of (1-Methylpiperidin-3-yl)methanamine, the publication is Bioorganic & Medicinal Chemistry Letters (2008), 18(11), 3251-3255, database is CAplus and MEDLINE.

A computer-aided drug design strategy leads to the identification of a new class of p38 inhibitors based on the 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) scaffold. The tolyl triazole amides provided a potent platform amenable to optimization. Further exploration leads to compounds with greater than 100-fold improvement in binding affinity to p38. Derivatives prepared to alter the physicochem. properties produced inhibitors with IC50‘s in human whole blood as low as 83 nM.

Bioorganic & Medicinal Chemistry Letters published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Safety of (1-Methylpiperidin-3-yl)methanamine.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Hu, Ziwei’s team published research in ACS Medicinal Chemistry Letters in 10 | CAS: 14613-37-7

ACS Medicinal Chemistry Letters published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Formula: C7H16N2.

Hu, Ziwei published the artcileIdentification of Human Toll-like Receptor 2-Agonistic Activity in Dihydropyridine-Quinolone Carboxamides, Formula: C7H16N2, the publication is ACS Medicinal Chemistry Letters (2019), 10(1), 132-136, database is CAplus and MEDLINE.

Using a multiplexed, reporter gene-based, high-throughput screen, we identified 9-fluoro-7-hydroxy-3-methyl-5-oxo-N-(pyridin-3-ylmethyl)-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-6-carboxamide as a TLR2 agonist. Preliminary structure-activity relationship studies on the carboxamide moiety led to the identification of analogs that induce chemokines and cytokines in a TLR2-dependent manner. These results represent new leads for the development of vaccine adjuvants.

ACS Medicinal Chemistry Letters published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Formula: C7H16N2.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Billin, Andrew N.’s team published research in ACS Chemical Biology in 11 | CAS: 14613-37-7

ACS Chemical Biology published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Name: (1-Methylpiperidin-3-yl)methanamine.

Billin, Andrew N. published the artcileDiscovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle, Name: (1-Methylpiperidin-3-yl)methanamine, the publication is ACS Chemical Biology (2016), 11(2), 518-529, database is CAplus and MEDLINE.

Skeletal muscle progenitor stem cells (referred to as satellite cells) represent the primary pool of stem cells in adult skeletal muscle responsible for the generation of new skeletal muscle in response to injury. Satellite cells derived from aged muscle display a significant reduction in regenerative capacity to form functional muscle. This decrease in functional recovery has been attributed to a decrease in proliferative capacity of satellite cells. Hence, agents that enhance the proliferative abilities of satellite cells may hold promise as therapies for a variety of pathol. settings, including repair of injured muscle and age- or disease-associated muscle wasting. Through phenotypic screening of isolated murine satellite cells, we identified a series of 2,4-diaminopyrimidines (e.g., 2) that increased satellite cell proliferation. Importantly, compound 2 was effective in accelerating repair of damaged skeletal muscle in an in vivo mouse model of skeletal muscle injury. While these compounds were originally prepared as c-Jun N-terminal kinase 1 (JNK-1) inhibitors, structure-activity analyses indicated JNK-1 inhibition does not correlate with satellite cell activity. Screening against a broad panel of kinases did not result in identification of an obvious mol. target, so we conducted cell-based proteomics experiments in an attempt to identify the mol. target(s) responsible for the potentiation of the satellite cell proliferation. These data provide the foundation for future efforts to design improved small mols. as potential therapeutics for muscle repair and regeneration.

ACS Chemical Biology published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Name: (1-Methylpiperidin-3-yl)methanamine.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Quevedo, Camilo E.’s team published research in Bioorganic & Medicinal Chemistry in 28 | CAS: 14613-37-7

Bioorganic & Medicinal Chemistry published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Formula: C7H16N2.

Quevedo, Camilo E. published the artcileAminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family, Formula: C7H16N2, the publication is Bioorganic & Medicinal Chemistry (2020), 28(22), 115724, database is CAplus and MEDLINE.

We have previously reported the discovery of a series of rhodanine-based inhibitors of the PIM family of serine/threonine kinases. Here we described the optimization of those compounds to improve their physicochem. and ADME properties as well as reducing their off-targets activities against other kinases. Through mol. modeling and systematic structure activity relationship (SAR) studies, advanced mols. with high inhibitory potency, reduced off-target activity and minimal efflux were identified as new pan-PIM inhibitors. One example of an early lead, I, was found to inhibit PIMs with nanomolar potency (15 nM for PIM1), inhibit proliferation of two PIM-expressing leukemic cancer cell lines, MV4-11 and K562, and to reduce intracellular phosphorylation of a PIM substrate in a concentration dependent manner.

Bioorganic & Medicinal Chemistry published new progress about 14613-37-7. 14613-37-7 belongs to piperidines, auxiliary class Piperidine,Amine, name is (1-Methylpiperidin-3-yl)methanamine, and the molecular formula is C7H16N2, Formula: C7H16N2.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Pesci, Elisabetta’s team published research in Journal of Medicinal Chemistry in 58 | CAS: 39546-32-2

Journal of Medicinal Chemistry published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, Computed Properties of 39546-32-2.

Pesci, Elisabetta published the artcileNovel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis, Computed Properties of 39546-32-2, the publication is Journal of Medicinal Chemistry (2015), 58(24), 9697-9711, database is CAplus and MEDLINE.

Cystic fibrosis (CF) is a lethal genetic disease caused by mutations of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) with a prevalence of the ΔF508 mutation. Whereas the detailed mechanisms underlying disease have yet to be fully elucidated, recent breakthroughs in clin. trials have demonstrated that CFTR dysfunction can be corrected by drug-like mols. On the basis of this success, a screening campaign was carried out, seeking new drug-like compounds able to rescue ΔF508-CFTR that led to the discovery of a novel series of correctors based on a tetrahydropyrido[4,3-d]pyrimidine core. These mols. proved to be soluble, cell-permeable, and active in a disease relevant functional-assay. The series was then further optimized with emphasis on biol. data from multiple cell systems while keeping physicochem. properties under strict control. Three mols. were found to have promising profiles, and among them I confirmed the low metabolic data observed with CYP3A4 also in the intrinsic clearance assay. The pharmacol. and ADME profile of this corrector series hold promise for the development of more efficacious compounds to be explored for therapeutic use in CF.

Journal of Medicinal Chemistry published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, Computed Properties of 39546-32-2.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Negatu, Dereje Abate’s team published research in Antimicrobial Agents and Chemotherapy in 65 | CAS: 39546-32-2

Antimicrobial Agents and Chemotherapy published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, HPLC of Formula: 39546-32-2.

Negatu, Dereje Abate published the artcilePiperidine-4-carboxamides target DNA gyrase in Mycobacterium abscessus, HPLC of Formula: 39546-32-2, the publication is Antimicrobial Agents and Chemotherapy (2021), 65(8), e00676, database is CAplus and MEDLINE.

New, more-effective drugs for the treatment of lung disease caused by nontuberculous mycobacteria (NTM) are needed. Among NTM opportunistic pathogens, Mycobacterium abscessus is the most difficult to cure and intrinsically multidrug resistant. In a whole-cell screen of a compound collection active against Mycobacterium tuberculosis, we previously identified the piperidine-4-carboxamide (P4C) MMV688844 (844) as a hit against M. abscessus. Here, we identified a more potent analog of 844 and showed that both the parent and improved analog retain activity against strains representing all three subspecies of the M. abscessus complex. Furthermore, P4Cs showed bactericidal and antibiofilm activity. Spontaneous resistance against the P4Cs emerged at a frequency of 10-8/CFU and mapped to gyrA and gyrB encoding the subunits of DNA gyrase. Biochem. studies with recombinant M. abscessus DNA gyrase showed that P4Cs inhibit the wild-type enzyme but not the P4C-resistant mutant. P4C-resistant strains showed limited cross-resistance to the fluoroquinolone moxifloxacin, which is in clin. use for the treatment of macrolide-resistant M. abscessus disease, and no cross-resistance to the benzimidazole SPR719, a novel DNA gyrase inhibitor in clin. development for the treatment of mycobacterial diseases. Analyses of P4Cs in recA promoter-based DNA damage reporter strains showed induction of recA promoter activity in the wild type but not in the P4C-resistant mutant background. This indicates that P4Cs, similar to fluoroquinolones, cause DNA gyrase-mediated DNA damage. Together, our results show that P4Cs present a novel class of mycobacterial DNA gyrase inhibitors with attractive antimicrobial activities against the M. abscessus complex.

Antimicrobial Agents and Chemotherapy published new progress about 39546-32-2. 39546-32-2 belongs to piperidines, auxiliary class Piperidine,Amine,Amide, name is Piperidine-4-carboxamide, and the molecular formula is C6H12N2O, HPLC of Formula: 39546-32-2.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Chen, Ching-Hsiu’s team published research in Journal of Pharmaceutical Sciences in 66 | CAS: 13444-24-1

Journal of Pharmaceutical Sciences published new progress about 13444-24-1. 13444-24-1 belongs to piperidines, auxiliary class Piperidine,Alcohol, name is 1-Ethylpiperidin-3-ol, and the molecular formula is C7H15NO, Application In Synthesis of 13444-24-1.

Chen, Ching-Hsiu published the artcileMetabolism of N-ethyl-3-piperidyl benzilate in rats, Application In Synthesis of 13444-24-1, the publication is Journal of Pharmaceutical Sciences (1977), 66(7), 931-5, database is CAplus and MEDLINE.

The metabolic fate of N-ethyl-3-piperidyl benzilate-HCl (I) [5957-24-4] and its potential metabolites 3-piperidyl benzilate-HCl (II) [60573-85-5], N-ethyl-3-hydroxy-piperidine-HCl (III) [5396-73-6], and 3-hydroxypiperidine-HCl (IV) [64051-79-2] was studied. Incubation of I with rat liver homogenates resulted in the formation of II and III. Only a trace of unchanged drug appeared in the urine after intraperitoneal injection of I. Approx. 9% of the injected dose of I was excreted in urine as III and 2% in the form of metabolites that produced III after acid hydrolysis. After i.p. injection of II n rats, 18% of the dose was excreted in urine as IV. Approx. 26% of the injected dose of III was present in urine as the unchanged drug, and 63% of the dose was excreted in the urine in the form of conjugates that produced III on acid hydrolysis. Urine of rats injected with IV contained approx. 50% of the injected dose as the unchanged drug and 50% of the dose in the form of a conjugate that produced IV on acid hydrolysis. The identity of the metabolites in extracts from urine was established by GLC-mass spectrometry. Thus, hydrolysis was one metabolic pathway for I and II. The major routes of elimination of these compounds are not yet known and may include excretion in feces or metabolic transformations resulting in the degradation of the piperidine ring.

Journal of Pharmaceutical Sciences published new progress about 13444-24-1. 13444-24-1 belongs to piperidines, auxiliary class Piperidine,Alcohol, name is 1-Ethylpiperidin-3-ol, and the molecular formula is C7H15NO, Application In Synthesis of 13444-24-1.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem

 

Biel, John H.’s team published research in Journal of Organic Chemistry in 26 | CAS: 13444-24-1

Journal of Organic Chemistry published new progress about 13444-24-1. 13444-24-1 belongs to piperidines, auxiliary class Piperidine,Alcohol, name is 1-Ethylpiperidin-3-ol, and the molecular formula is C7H15NO, Related Products of piperidines.

Biel, John H. published the artcileCentral stimulants. II. Cholinergic blocking agents, Related Products of piperidines, the publication is Journal of Organic Chemistry (1961), 4096-103, database is CAplus.

cf. CA 48, 694a.–The initial finding that certain disubstituted glycolates of 3-hydroxypiperidine (I) could elicit potent psychotomimetic and antidepressant effects in man suggested a possible relationship between cholinergic blockade and central nervous system stimulatory properties. To investigate this hypothesis, a structural variety of esters of the hydroxypiperidines, hydroxypyrrolidines, and hydroxymethylpyrrolidines was synthesized. The following aspects of this investigation was discussed: (1) the ring contraction obtained during the reaction of the 3-halopiperidines with the free acid; (2) the thermal ring expansion during the distillation of the basic esters; (3) the structure activity relationships with regard to (a) central nervous system stimulation, (b) anticholinergic effects, and (c) the correlation of psychopharmacologic action with cholinergic blockade; (4) the use of these psychotogenic drugs as possible tools in the development of potential antagonists. At present, the conclusion appeared warranted that potent anticholinergic properties were a pharmacol. prerequisite for the characteristic central nervous system effects evoked by this group of compounds The assay method for the isomer ratio of N-ethyl-3-piperidyl phenylcyclopentylglyeolate (II) and N-ethyl-2-pyrrolidyhnethyl phenyleyclopentylglycolate (III) involved an acid hydrolysis of the esters, the extraction of the resulting alcs., and infrared spectrophotometric determination of the ratio of the resulting alcs. Pure samples of N-ethyl-3-hydroxypiperidine (IV) and N-ethyl-2-hydroxymethylpyrrolidine (V) were prepared and infrared spectra taken. Standard mixts, were prepared from IV and V and the absorbance ratio plotted against % pyrrolidyl isomer and given in a figure. Samples of II and III were prepared by ester interchange using pure IV and V. Subsequent hydrolysis of II and III afforded alc. fragments with infrared spectra identical with that of starting materials. Thus, ring contraction did not occur during the esterification of the halopiperidine, resulting in a mixture of isomers. The procedure for the assay was described. N-Ethyl-3-chloropiperidine (VI) and 34.2 g. benzilic acid in 400 ml. iso-PrOH refluxed 12 hrs., evaporated, the residue taken up in H2O, made alk., the organic phase extracted with Et2O, dried, evaporated, and the basic ether residue convetted to the HCl salt in iso-PrOH gave 33 g. solids containing 55% N-ethyl-3-piperidyl benzilate-HCl (VII), m. 163-7° (iso-PrOH). The mother liquor from the recrystallization was set aside to give mother liquor A for part B of the experiment The solid recrystallized gave 12.5 g. pure VII, m. 191-2° (alc.). The mother liquor A concentrated to one-fourth gave 12.5 g. N-ethyl-2pyrrolidylmethyl benzilate-HCl (VIII), m. 145-7°. Phenyl-cyclopentylglycolic acid (108.9 g.), 81.1 g. VI, and 625 cc. iso-PrOH refluxed 40 hrs., concentrated to dryness, the residue dissolved in 1 1. H2O, extracted with Et2O, saturated with NaHCO3 solution, and the combined ether extracted dried, and evaporated The residue in 500 ml. Me2CO treated with Et2O-HCl gave 111.5 g. mixture A 91.5 g. sample recrystallized gave 52 g. VII. The average isomer ratio from various experiments of VIII versus VII was found to be 70:30 as determined by infrared spectroscopy. The filtrate gave 35.3 g. residue, m. 177-8°. The isomer ratio was the same as for the higher-melting material. The lower m.p. may be due to a different diastereoisomeric mixture Me phenylcyclopentylglyeolate (106 g.), 64.5 g. N-ethyl-3hydroxypiperidine (IX), 1.5 g. NaOMe, and 1.26 1. heptane refluxed, the catalyst removed by filtration, the filtrate washed, the organic phase dried, evaporated, and the 136.5 g. residue treated with Et2O-HCl gave 88 g. N-ethyl-3-piperidyl phenyleyclopentylgiycolate-HCl (X), m. 214-16° (isoPrOH). X by infrared spectrum was pure. A 70:30 mixture of VII-VIII (55 g.) converted to the free base esters with aqueous NaHCO3, extracted with Et2O, evaporated, and the high-boiling ester distilled in vacuo gave 45 g. product, b0.05, 166-8°. Conversion of the base to the HCl salt gave the high-melting stereoisomer, m. 232-3°. The filtrate afforded 22% X. In subsequent runs this yield was as high as 40%. KOH (5.6 g.), 10.1 g. 2-pyrrolidyhnethanol, 11 g. EtBr, and 100 cc. alc. heated 2 hrs. at 100° in a pressure bottle gave 9 g. N-ethyl-2-pyrrolidylmethanol (XI), b2 8 50-1°. XI (10.6 g.), 19.3 g. Me phenylcyclopentylglycolate, 1 g. NaOMe, and 200 cc. heptane refluxed 4 hrs., the filtrate washed, dried, steam distilled, and the 23.7 g. product acidified with HCl in Et2O gave 21.3 g. N-ethyl-2-pyrrolidylmethyl phenylcyclopentylglycolate-HCl (XII), m. 185-6° (MeCN). XII was shown by infrared assay to be pure. 3-Hydroxypiperidine (XIII) (65 g.) and 150 cc. PhMe refluxed 6 hrs. with 56.5 g. β-benzyloxyethyl chloride, the solid collected, the filtrate concentrated, and the product distilled gave 60 g. N-(βbenzyloxyethyl)-3-hydroxypiperidine (XIV), b1.1 150°, n25D 1.5321. XIV (38.8 g.), 36.3 g. Me benzilate, 0.6 g. NaOMe, and 400 cc. heptane refluxed, evaporated, and the 67 g. product in Me2CO treated with HCl gave 50 g. N-(β-benzyloxyethyl)3-piperidyl benzilate-HCl (XV), m. 172° (MeOH). XV (24.1 g.), 3 g. Pd-C, and 150 cc. MeOH reduced at 60 lb./sq. in. at 25° gave 18.2 g. N-(β-hydroxyethyl)-3-piperidyl henzilate-HCl, m. 150-1°. N-Benzyl-3-piperidyl benzilate (20’g.), 3 g. AcOH, 3.5 g. 10% Pd-C, and 200 ml. McOH reduced at 25° at 60 lb./sq. in. H pressure and acidified gave 16.8 g. 3-piperidyl benzilate-HCl, m. 178-80° NaOH (14.3 g.), 36 g. XIII, and 300 co. 90% alc. refluxed 3 hrs. with 42 g.β-(4-methylpiperazino)ethyl chloride-HCl gave 16.3 g. 1- [β-(3-hydroxypiperidino) ethyl] 4-methylpiperazine, b0.6 120-2°, n25D 1.5061. XIII (101.4 g.) in 500 co. C6H6 refuxed 4 hrs. with 53.8 g. β-dimethylaminoethyl chloride gave 73.2 g. N-(β-dimethylaminoethyl)-3-hydroxypiperidine, b0.9 92-4°, n25D 1.4822. XIII (68 g.), 67 g. NEt3, 132 g. a-bromoacetal, and 400 cc. PhMe refluxed 4 hrs., the HBr salt removed, the filtrate washed, and distilled gave 91 g. a-(3-hydroxypiperidino)acetal (XVI), b0.6 98-100°, n25D 1.4632. XVI (32.6 g.) left 3 hrs. at 25° under N with 75 cc. concentrated HCl, evaporated, the residue diluted with 150 cc. H2O, neutralized, treated overnight at 25° with 17.5 g. 1-amino-4methylpiperazine, the oil extracted with tetrahydrofuran, and concentrated gave 32.4 g. crude hydrazone (XVII). XVII in 100 cc. tetrahydrofuran refluxed 4 hrs. with 5.2 g. LiAlH4 gave 23.7 g. 1-methyl-4-[β(2-hydroxypiperidino)ethylamino]piperazine, b0..03 147-9°. XIII (50.5 g.) and 50.5 g. H2O with 128 g. 30% H2SO4 treated during I hr. with 85 g. NaNO2 and 150 cc. H2O, the solution stirred 1 hr. at 25°, the oily layer extracted with CHCl3, the combined extracts washed with 40% KOH, and evaporated gave 40.9 g. N-nitroso-3-hydroxypiperidine (XVIII). XVIII (40.9 g.) in 300 co. tetrahydrofuran treated in 1.5 hrs. with 17.5 g. LiAlH4 in 500 cc. tetrahydrofuran, the mixture refluxed 1 hr., decomposed, and the product distilled gave 25.9 g. 1-amino-3-hydroxypiperidine(XIX),b0.45 84-6°. XIX(60g.) and 38.5 g. Et formate refluxed 5 hrs., and the product distilled gave 41.5 g. N-formylamino-3-hydroxypiperidine (XIXa), b1.2 165°. XIXa (40.3 g.) and 250 cc. tetrahydrofuran added in 1.5 hrs. to 13.3 g. LiAlH4 in 500 cc. tetrahydrofuran, refluxed 3 hrs., decomposed with 40 cc. 40% aqueous KOH, the salts removed, and the product distilled gave 25.9 g. N-methylamino-3-hydroxypiperidine, b1.2 83-6°, n25D 1.4972. XIII (50 g.), 50 g. NEt3, 62.5 g. PhCH2Cl, and 250 cc. PhMe refluxed 4 hrs. and the product distilled gave 65 g. Nbenzyl-4-hydroxypiperidine, b0.7 122-3°, n25D 1.5514. The following XX.HCl were prepared (C5H9 = cyclopentyl) (R, R1, R2, ring position, Y, % yield, m.p. given): Et, Ph, C5H9, 3, –, –, 212-13° Me, C6H11, Ph, 3, –, 76, 222° H, Ph, Ph, 3, –, 96.5, 178-80° PhCH2, Ph, Ph, 3, –, 75.0, 222-3° Me2NCH2CH2, Ph, Ph, 3, –, 68.0, 237-8° PhCH2OCH2CH2, Ph, Ph, 3, –, 69, 172° PhCH2, Ph, Ph, 2, CH2, 67.2,211° HOCH2CH2, Ph, Ph, 3, –, 98.5, 1522.5° H, Ph, Ph, 2, CH2, 81, 199-200° Me, Ph, Ph, 2, CH2, 44.3,230° PhCH2, Ph, Ph, 4, –, 78.2, 194-5° Me, Ph, Ph, 2, CHCH3, 31.4, 230° H, Ph, Ph, 4, –, 88, 1802° Me, C5H9, Ph, 3, –, 58.7, 209-10° Et, Ph, C5H9, 4, –, 43.5, 220-1°; Me, Ph, Ph, 4, –, –, 213-14° Me, Ph, Ph, 2, CH2CH2, 26.7, 145-7° MeNH, Ph, Ph, 3, –, 30.0, 158-60° Me, Ph, Ph, 4, –, 53, 215-16°. The following XXIII.HCl were prepared (R, R1, R2, ring position, Y, % yield, m.p. given): Et, Ph, C5H9, 2, CH2, 30, 186° Me, Ph, C5H9, 3, –, 31, 169-70° Et, Ph, C5H9, 3, –, 42, 165-6°. The following compounds were prepared (% yield and m.p. given): 3-pyridylmethyl benzilate, 29.2,189° N-methyl-3piperidyl methyldiphenylacetate, 71, 216-17° 3-piperidyl diphenylacetate, 56.0, 171-2° XXI, 53, 257° XXII, 77, 237-9°. The central nervous system stimulation and E.D.50 values were given in a table for 36 compounds of the above types.

Journal of Organic Chemistry published new progress about 13444-24-1. 13444-24-1 belongs to piperidines, auxiliary class Piperidine,Alcohol, name is 1-Ethylpiperidin-3-ol, and the molecular formula is C7H15NO, Related Products of piperidines.

Referemce:
https://en.wikipedia.org/wiki/Piperidine,
Piperidine | C5H11N – PubChem